NEOMATRIX is a individualised therapeutic cancer vaccine against tumour specific antigens, called neoantigens, arising from somatic gene mutations in malignant cells during neoplastic transformation. The tailored vaccine is intended for use as therapeutic vaccination in patients with locally advanced or metastatic solid tumours.
Company Details
- Employees
- 7
- Address
- Via Castel Romano, 100, Rome,italy
- Industry
- Biotechnology
- Website
- http://www.neomatrixbiotech.com
- HQ
- Rome
Neomatrix Questions
Neomatrix's website is http://www.neomatrixbiotech.com
Neomatrix's LinkedIn profile is https://it.linkedin.com/company/neomatrixbiotech
Neomatrix has
7 employees.
View email and phone details for 7
employees at Neomatrix.
Neomatrix's industry is
Biotechnology
Neomatrix's top competitors are
Vitares,
Reithera,
Takis,
Irbm,
Neomatrix, Inc.,
Neomatrix Ltd,
Neomatrix,
Aptadir Therapeutics,
Evvivax,
Bionseek Srl.
Neomatrix's categories are Biotechnology
